{"name":"Humanigen, Inc.","slug":"humanigen-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":2514000,"revenueGrowth":-30.1,"grossMargin":0,"rdSpend":55210000,"netIncome":-70730000,"cash":10155000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPMmpkdm12OGpPV3NUT2dzQ2dZRk9OWTQ2eEFqTmJCTG51SkJmQTRCQUZqWmc2UkhOUWJHQm53TzVkX2Z6bnpjQ2tPMUYwVFpmbHpyR3EyMlVCMmJ2UE1pNEhqMVhpelZiZFg1TDZ1dVltUEhHWHg4d2hTcWFjZHhkeWFLZy1Mb1A2QS10VmEzbnJzbTlrUmxoVUxReGJ1Q3IzRHRtRWtmdUxNZTI2MEI4?oc=5","date":"2026-03-12","type":"pipeline","source":"Investing.com","summary":"Poolbeg Pharma adds clinical expert to advisory board - Investing.com","headline":"Poolbeg Pharma adds clinical expert to advisory board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQclVRUkxhZjJlUWpiT1RZaWtoV0JYU2xqM1ByN2FGS1ZkQnppQmY3ZmNDSFFYQV96MXljU2EyeVItel8xNWY4OG5pQnl1WFVGWk5mRzdaWHROUy1vMkkwZzVramJDY1N1Q0k0eGJUMFdOaFZiRVpyUEYyY2lVM3FyRkVIVndiQWppcFpQejVnS2J1RkdnaUNldl9YZWYxTE5zdGlOWVU4dW9Wc0hOdWc?oc=5","date":"2026-03-12","type":"pipeline","source":"Investing.com UK","summary":"Poolbeg Pharma adds clinical expert to advisory board By Investing.com - Investing.com UK","headline":"Poolbeg Pharma adds clinical expert to advisory board By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQSzVzTkdiQ2o3b2FGcmtUX3Njd0VTRzhkRlJGZTdrbHI2anp1Zm9kdFdSUjlqYnZMMlpGY3p1a0JjbGZCR0hEVWhrR2NPQWIzUE1qZnpXbGVjVzF1WThXcEc0cktDdUZDYVVjdG5DV1ZFMkNPaERVMThOaFQ1Z0Y5X3RsaGdDUXJBM1M1cmpCRVdjVEpTV3k1RThuS2dHcFNxaHZtT3pueXpXRlI2MEJFUFFqeXcxU1FIcDRsMU5oVnVENXpVR1k1WE83eDRNZw?oc=5","date":"2025-12-16","type":"pipeline","source":"Business Wire","summary":"Humanetics Corporation Appoints Timothy E. Morris as Chief Operating Officer - Business Wire","headline":"Humanetics Corporation Appoints Timothy E. Morris as Chief Operating Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdTM1M0ptOFkyLVlMcXRRNWw1eG5RNk9OMXpla2p3NE1IbzdadXJhOU45RFF3Qzlhb24xS0hmWVVoUXVGTDhpc21TYXczVFM2T3psRkoyU2dqVFdGVVhIdm10X2l1S2FKSDBvV3ZiNUJvczBNTkZrZU14QVFESU5vTF9sMjBVelpBVDUya2JDaWZZcHEtV1VQdGl6SQ?oc=5","date":"2025-08-08","type":"pipeline","source":"vocal.media","summary":"Cameron Durrant – A Journey from Medicine to Global Pharma Leadership - vocal.media","headline":"Cameron Durrant – A Journey from Medicine to Global Pharma Leadership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOUXVzSV9BblI2NzQybnAtYkREV2U4WmZ1XzRxZE1SUEFTZHA2YVE0THotSUhhRVJENnBQYnl2Q0NOTGlENGZIbXdoeWczU0FBWmFoMnhXRkp6TWZzSUlHc21KSGhKTktySndUUGJYWUhvRDMtNXE3MTkzUzFzeDNJd2R5a2Y4SVRuaFVMS19TYldsUFYwUzUw?oc=5","date":"2024-02-12","type":"pipeline","source":"Fierce Biotech","summary":"Biotech bankruptcies hit 10-year peak in 2023 - Fierce Biotech","headline":"Biotech bankruptcies hit 10-year peak in 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOYU13b3VxaWpUNms5NldFRURlUG5YN05jQk8wT2dsNXdndmtzejVvcE41NUFZdm56N2c0dzFOQ0o0Tk9wb2t2dVJPUlZxVnV1OUNnRmgyTGh0UHJpTDVlaUJ2UW1xYzZEb1Z5akhJQzFHdDhtV0hZekFTWGRpcXR0WUZzY1pTZVRCX2ZtSWVKUkE1b3pSSkVfM2JjN2hIUQ?oc=5","date":"2024-02-01","type":"pipeline","source":"East Oregonian","summary":"Key biotech firm files Chapter 11 bankruptcy; will shut down - East Oregonian","headline":"Key biotech firm files Chapter 11 bankruptcy; will shut down","sentiment":"neutral"},{"date":"2024-01-08","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPb1l2ME1BYzNaQkN3YjdSdkdpSzhWMEFUcWpaUXJpUEljVm1TZGRpUm9tdWVjd0ppQUdSYkZnaVg0X3BlVXlZTF80Z09iRzBMeWlLc3Vlem9pN2E1R3VKQkZ3SUdoZ3p2aUVqQXBRX0ZlT1BucXV3QWtBRFQwNW1QR1JyeXNfN1d5T1FjdS1iQXJfNmNNYWFyV2lHUFJvZw?oc=5","date":"2024-01-03","type":"pipeline","source":"WSJ","summary":"Covid-19 Treatment Developer Humanigen Files for Bankruptcy - WSJ","headline":"Covid-19 Treatment Developer Humanigen Files for Bankruptcy","sentiment":"neutral"},{"date":"2023-09-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOSjlWdzBxOFdGSFNDR2diNl9vV2V0anl3MG1wb2ozR2U1RzRDYnZtMFlxSk9HYVpKTGtXTWdPTGpXQW1xU1M2UHN5NExwNkxvY015UFd5NENvU0o0bGhpdVJaOVRtY2Z0TmpieGlOeV96U0lmS0pXOXFIQXZRS0FMY2NFQlNWdUpBcHRMSzY2MGY2cElIak9yYTBmR2dtWlc4UVdaN0pJeENuWXNaY0wyUjN2YXNjUWFGSzI4a003RWlUQ0E2VWJzRG0wSEd1UVJ4dDAxbE1qLXI5U2NLbThYTw?oc=5","date":"2023-07-28","type":"pipeline","source":"proactiveinvestors.com","summary":"Humanigen stock removed from S&P Total Market Index as firm faces bankruptcy - proactiveinvestors.com","headline":"Humanigen stock removed from S&P Total Market Index as firm faces bankruptcy","sentiment":"neutral"},{"date":"2023-07-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2023-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2023-04-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2023-04-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2023-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC","headline":"Annual Report (10-K) Filed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":2514000,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":2514000,"period":"2022-12-31"},{"value":3595000,"period":"2021-12-31"},{"value":312000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":55210000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-70730000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":10155000,"cashHistory":[],"totalAssets":11195000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}